81 related articles for article (PubMed ID: 6431676)
21. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
[TBL] [Abstract][Full Text] [Related]
22. Endometrial morphology after 6 months of continuous treatment with a new gonadotropin-releasing hormone superagonist for contraception.
Gudmundsson JA; Lundkvist O; Bergquist C; Lindgren A; Nillius SJ
Fertil Steril; 1987 Jul; 48(1):52-6. PubMed ID: 2954864
[TBL] [Abstract][Full Text] [Related]
23. Effects of chronic luteinizing hormone-releasing hormone agonist treatment on dysfunctional uterine bleeding in the stumptailed macaque.
Fraser HM; Shaw RW
Acta Endocrinol (Copenh); 1984 Jul; 106(3):381-6. PubMed ID: 6429990
[TBL] [Abstract][Full Text] [Related]
24. A new superagonist of GnRH for inhibition of ovulation in women.
Nillius SJ; Gudmundsson J; Bergquist C
Ups J Med Sci; 1984; 89(2):147-50. PubMed ID: 6235657
[TBL] [Abstract][Full Text] [Related]
25. Peptide contraception by inhibition of ovulation with intranasal GnRH superagonist: clinical and metabolic aspects.
Gudmundsson JA; Bergquist C; Nillius SJ
Prog Clin Biol Res; 1986; 225():337-51. PubMed ID: 2947248
[TBL] [Abstract][Full Text] [Related]
26. Dose-dependent inhibition of pituitary-ovarian function during administration of a gonadotropin-releasing hormone agonistic analog (nafarelin).
Monroe SE; Blumenfeld Z; Andreyko JL; Schriock E; Henzl MR; Jaffe RB
J Clin Endocrinol Metab; 1986 Dec; 63(6):1334-41. PubMed ID: 2946710
[TBL] [Abstract][Full Text] [Related]
27. Reversible suppression of menstruation with progesterone antagonists in rhesus macaques.
Slayden OD; Chwalisz K; Brenner RM
Hum Reprod; 2001 Aug; 16(8):1562-74. PubMed ID: 11473944
[TBL] [Abstract][Full Text] [Related]
28. Chronic treatment with a LH-RH-agonist: a new contraceptive method?
Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J
Acta Eur Fertil; 1981 Sep; 12(3):275-6. PubMed ID: 6803498
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
[TBL] [Abstract][Full Text] [Related]
30. GnRH agonist for postpartum contraception: biochemical, hormonal and endometrial effects.
Vega RR; Barraza-Vázquez A; Vega MG; Fernández-González EM; Mayagoitia SB
Adv Contracept; 1996 Mar; 12(1):15-25. PubMed ID: 8739513
[TBL] [Abstract][Full Text] [Related]
31. Luteolytic activity of LHRH and [D-Ser(TBU)6, des-Gly-NH2(10)]LHRH ethylamide: a new and physiological approach to contraception in women.
Lemay A; Labrie F; Raynaud JP
Int J Fertil; 1980; 25(3):203-12. PubMed ID: 6108931
[TBL] [Abstract][Full Text] [Related]
32. [Clinical observations on LRH-A used for contraception by luteolysis in normal women--analysis of 88 cases].
Lu RK; Chen HY; Liu Y; Zhang L; He YJ; Ge LJ; Yuan XW; Qui XD
Shengzhi Yu Biyun; 1987; 7(1):39-40, 45-7. PubMed ID: 12341309
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of cyclic attacks of acute intermittent porphyria with an LH-RH agonist administered by the intranasal route].
Semon C; Dupond JL; Mallet H; Grandmottet-Cambefort C; Humbert P
Ann Endocrinol (Paris); 1986; 47(5):399-402. PubMed ID: 3103522
[TBL] [Abstract][Full Text] [Related]
34. [Clinical study on LRH-A contraception by luteolysis].
Lu RK
Zhonghua Fu Chan Ke Za Zhi; 1989 Jan; 24(1):26-8, 58. PubMed ID: 2667912
[TBL] [Abstract][Full Text] [Related]
35. [The influence of long-term medication with the LH-RH analogue buserelin on the regulation of the menstrual cycle (author's transl)].
Hardt W; Schmidt-Gollwitzer M; von der Ohe M; Nevinny-Stickel J
Geburtshilfe Frauenheilkd; 1981 Nov; 41(11):791-6. PubMed ID: 6797869
[TBL] [Abstract][Full Text] [Related]
36. [Ovarian suppression by the GnRH analog buserelin in the treatment of endometriosis. Clinical, biochemical and pelviscopic studies].
Raitz von Frentz M; Schweppe KW
Geburtshilfe Frauenheilkd; 1990 Aug; 50(8):634-9. PubMed ID: 2145192
[TBL] [Abstract][Full Text] [Related]
37. Luteinizing hormone releasing hormone agonist for postpartum contraception.
Mayagoitia SB; Hernández-Morales C; Macías AM; Vega RR
Adv Contracept; 1996 Mar; 12(1):27-41. PubMed ID: 8739514
[TBL] [Abstract][Full Text] [Related]
38. Contraceptive potential of a mifepristone-nomegestrol acetate sequential regimen in women.
Croxatto HB; Salvatierra AM; Fuentealba B; Massai R
Hum Reprod; 1998 Dec; 13(12):3297-302. PubMed ID: 9886502
[TBL] [Abstract][Full Text] [Related]
39. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamics of a contraceptive vaginal ring releasing norethindrone and estradiol: ovarian function, bleeding control and lipoprotein patterns.
Victor A; Lithell H; Selinus I; Vessby B
Ups J Med Sci; 1984; 89(2):179-88. PubMed ID: 6380076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
